← Back to Search

Nerve Stimulation Device

Transvenous Nerve Stimulation for Sleep Apnea

N/A
Recruiting
Research Sponsored by Respicardia, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject with moderate to severe central sleep apnea is undergoing a de novo commercial remedē® System implant procedure or other de novo transvenous cardiac implantable device procedure including a pacemaker or an implantable cardiac defibrillator
Subject is at least 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure (immediately post-stimulation)
Awards & highlights

Study Summary

This trial tests if a different implant site for a pacemaker/defibrillator affects breathing/airway during the procedure.

Who is the study for?
This trial is for adults over 18 with moderate to severe central sleep apnea who are getting a new remedē® System or other cardiac device like a pacemaker. They must be able to consent and not have significant upper airway issues, nerve problems affecting the tongue, prior neck surgery, BMI over 40, unstable health conditions, pregnancy plans, dye allergies that can't be managed, past oral cavity surgeries impacting breathing or use muscle relaxants without approval.Check my eligibility
What is being tested?
The Janus Feasibility Study is testing if changing where transvenous leads are placed during implant procedures of devices like the remedē® System affects breathing and airway function in patients with sleep apnea.See study design
What are the potential side effects?
Potential side effects may include discomfort at the lead placement site, possible respiratory changes due to stimulation adjustments and general risks associated with implant procedures such as infection or bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am getting a new device implanted to help with severe sleep apnea or heart rhythm.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure (immediately post-stimulation)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure (immediately post-stimulation) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in respiration and airway physiology

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transvenous nerve stimulationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Respicardia, Inc.Lead Sponsor
8 Previous Clinical Trials
967 Total Patients Enrolled
3 Trials studying Sleep Apnea
138 Patients Enrolled for Sleep Apnea
Kathy A McPherson, RN, MSNStudy DirectorRespicardia, Inc.
Tim Meyer, MS, PhDStudy DirectorRespicardia, Inc.

Media Library

Transvenous nerve stimulation (Nerve Stimulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT03985527 — N/A
Sleep Apnea Research Study Groups: Transvenous nerve stimulation
Sleep Apnea Clinical Trial 2023: Transvenous nerve stimulation Highlights & Side Effects. Trial Name: NCT03985527 — N/A
Transvenous nerve stimulation (Nerve Stimulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03985527 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
North Carolina
How old are they?
18 - 65
What site did they apply to?
Novant Health Forsyth Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Janus Feasibility Study
2020. "Janus Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03985527.
All > Sleep
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top